Required Information The following information applies to the questions displayed below) The December 31, 2021, unadjusted...
Required information [The following information applies to the questions displayed below.] The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 53,040 29,000 4,400 45,000 98,000 29,400 32,000 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation expense Utilities expense Advertising expense Totals 100,000...
Exercise 2-20 (Algo) Worksheet (Appendix 2A) [The following information applies to the questions displayed below.) The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 41,870 32,750 5,400 51,250 118,000 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation expense Utilities expense Advertising expense...
Check Required information Exercise 2-20 (Algo) Worksheet (Appendix 2A] (The following information applies to the questions displayed below.] The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 75,370 21,500 2,400 32,500 58,800 17,480 22,880 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation...
Required: 1. Prepare and complete a worksheet. 2. Prepare an income statement for 2021 and a balance sheet as of December 31, 2021. Required information [The following information applies to the questions displayed below.) The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 50,810 29,750 4,600 46,250 102,000 30,600 33,000 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries...
The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company’s year-end reporting date. Account Title Debits Credits Cash 46,340 Accounts receivable 31,250 Prepaid rent 5,000 Inventory 48,750 Equipment 110,000 Accumulated depreciation 33,000 Accounts payable 35,000 Salaries payable 0 Common stock 100,000 Retained earnings 32,500 Sales revenue 483,000 Cost of goods sold 289,800 Salaries expense 96,600 Rent expense 30,000 Depreciation expense 0 Utilities expense 19,320 Advertising expense 6,440 Totals 683,500 683,500...
The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date Credits Debits 75,370 21,500 2,400 32, see 58, eee 17,480 22,000 2 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation expense Utilities expense Advertising expense Totals 100,000 13,000 353,000 211,800 70,600 14,400 14,120 4.710 505,...
The December 31, 2021, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company's year-end reporting date. Credits Debits 41,870 32,750 5,400 51,250 118,000 Account Title Cash Accounts receivable Prepaid rent Inventory Equipment Accumulated depreciation Accounts payable Salaries payable Common stock Retained earnings Sales revenue Cost of goods sold Salaries expense Rent expense Depreciation expense Utilities expense Advertising expense Totals 35,400 37,000 0 100,000 35,500 503,000 301,800 100,600 32,400 20,120 6710 710,900 710,900 The...
Required information [The following information applies to the questions displayed below.) The December 31, 2021, unadjusted trial balance for Demon Deacons Corporation is presented below. Credit Accounts Cash Accounts Receivable Prepaid Rent Supplies Deferred Revenue Common Stock Retained Earnings Service Revenue Salaries Expense Debit $ 8, 800 13,800 5,760 2,800 $ 1,800 10,000 4,800 43,560 29,000 $60,160 $60, 160 At year-end, the following additional information is available. 1. The balance of Prepaid Rent, $5,760, represents payment on October 31, 2021,...
The December 31, 2018, unadjusted trial balance for the Wolkstein Drug Company is presented below. December 31 is the company’s fiscal year-end. Account TitleDebits Credits Cash70,910 Accounts receivable23,000 Prepaid rent2,800 Inventory35,000 Equipment66,000 Accumulated depreciation—equipment 19,800 Accounts payable 24,000 Salaries and wages payable 0 Common stock 100,000 Retained earnings 16,000 Sales revenue 373,000 Cost of goods sold223,800 Salaries and wages expense74,600 Rent expense16,800 Depreciation expense0 Utility expense14,920 Advertising expense4,970 Totals532,800 532,800 The following year-end adjusting entries are required: Depreciation expense for the year on the...
Required information [The following information applies to the questions displayed below.) The December 31, 2021, adjusted trial balance for Fightin' Blue Hens Corporation is presented below. Credit Debit $ 10,500 135,000 4,500 22,500 250,000 Accounts Cash Accounts Receivable Prepaid Rent Supplies Equipment Accumulated Depreciation Accounts Payable Salaries Payable Interest Payable Notes Payable (due in two years) Common Stock Retained Earnings Service Revenue Salaries Expense Rent Expense Depreciation Expense Interest Expense Totals $ 120,000 10,500 9,500 3,500 25,000 150,000 45,000 350,000...